WO2004060460A2 - Medical devices with cutting element. - Google Patents
Medical devices with cutting element. Download PDFInfo
- Publication number
- WO2004060460A2 WO2004060460A2 PCT/US2003/041852 US0341852W WO2004060460A2 WO 2004060460 A2 WO2004060460 A2 WO 2004060460A2 US 0341852 W US0341852 W US 0341852W WO 2004060460 A2 WO2004060460 A2 WO 2004060460A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- balloon
- cutting element
- cutting
- french
- stent
- Prior art date
Links
- 229910003460 diamond Inorganic materials 0.000 claims abstract description 19
- 239000010432 diamond Substances 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims description 25
- 229920000642 polymer Polymers 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 10
- 239000010410 layer Substances 0.000 claims description 8
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 238000005848 Knoop reaction Methods 0.000 claims description 3
- 239000004642 Polyimide Substances 0.000 claims description 3
- 229920001721 polyimide Polymers 0.000 claims description 3
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 3
- 239000013047 polymeric layer Substances 0.000 claims description 2
- 239000012858 resilient material Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 14
- -1 poly(vinylpyrrolidone) Polymers 0.000 description 12
- 238000002788 crimping Methods 0.000 description 6
- 238000002595 magnetic resonance imaging Methods 0.000 description 6
- 229940124597 therapeutic agent Drugs 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 4
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229910052692 Dysprosium Inorganic materials 0.000 description 3
- 229910052688 Gadolinium Inorganic materials 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 3
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000003193 general anesthetic agent Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 229910052758 niobium Inorganic materials 0.000 description 2
- 239000010955 niobium Substances 0.000 description 2
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- RBSXHDIPCIWOMG-UHFFFAOYSA-N 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea Chemical compound CCS(=O)(=O)C=1N=C2C=CC=CN2C=1S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 RBSXHDIPCIWOMG-UHFFFAOYSA-N 0.000 description 1
- UHKPXKGJFOKCGG-UHFFFAOYSA-N 2-methylprop-1-ene;styrene Chemical compound CC(C)=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 UHKPXKGJFOKCGG-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229910002518 CoFe2O4 Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 229910001080 W alloy Inorganic materials 0.000 description 1
- MOSURRVHVKOQHA-UHFFFAOYSA-N [Tb].[Dy] Chemical compound [Tb].[Dy] MOSURRVHVKOQHA-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- NLQFUUYNQFMIJW-UHFFFAOYSA-N dysprosium(III) oxide Inorganic materials O=[Dy]O[Dy]=O NLQFUUYNQFMIJW-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- CMIHHWBVHJVIGI-UHFFFAOYSA-N gadolinium(III) oxide Inorganic materials [O-2].[O-2].[O-2].[Gd+3].[Gd+3] CMIHHWBVHJVIGI-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000007517 polishing process Methods 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229910000314 transition metal oxide Inorganic materials 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
- A61F2002/8483—Barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0058—X-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
- A61M2025/1004—Balloons with folds, e.g. folded or multifolded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1086—Balloon catheters with special features or adapted for special applications having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
Definitions
- the invention relates to medical devices, such as medical balloons, catheters having balloons, and stents.
- the body includes various passageways such as arteries, other blood vessels, and other body lumens. These passageways sometimes become occluded by a tumor or restricted by plaque.
- balloon catheters can be used, for example, in angioplasty.
- a balloon catheter can include an inflatable and deflatable balloon carried by a long and narrow catheter body.
- the balloon is initially folded around the catheter body to reduce the radial profile of the balloon catheter for easy insertion into the body.
- the folded balloon can be delivered to a target location in the vessel, e.g., a portion occluded by plaque, by threading the balloon catheter over a guide wire emplaced in the vessel.
- the balloon is then inflated, e.g., by introducing a fluid into the interior of the balloon. Inflating the balloon can radially expand the vessel so that the vessel can permit an increased rate of blood flow. In some cases, it is desirable to incise at least a portion of the plaque, which can further widen the vessel and increase the rate of blood flow.
- the balloon is deflated and withdrawn from the body.
- the balloon catheter can also be used to position a medical device, such as a stent or a stent-graft, to open and/or to reinforce a blocked passageway.
- a medical device such as a stent or a stent-graft
- the stent can be delivered inside the body by a balloon catheter that supports the stent in a compacted or reduced-size form as the stent is transported to the target site.
- the balloon Upon reaching the site, the balloon can be inflated to deform and to fix the expanded stent at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.
- the invention relates to medical devices, such as medical balloons, catheters having balloons, stents, and stent-grafts.
- the invention features a medical device including one or more cutting elements, or atherotomes.
- the invention features a medical device including an inflatable balloon, a cutting element carried by the balloon, and a deformable member different than the balloon.
- the member is disposed over a portion of the cutting element.
- Embodiments can include one or more of the following features.
- the cutting element includes diamond.
- the cutting element includes a material having a hardness of greater than about 5,700 kg/mm .
- the cutting element has a cutting edge, and the deformable member, e.g., a polymer, extends over the cutting edge.
- the polymer can be a silicone rubber or a urethane.
- the device further includes a second member between the cutting element and the balloon, the second member having a hardness greater than the hardness of the deformable member.
- the second member can be a polyimide or a polyamide.
- the medical device does not include the deformable member.
- the device can include a plurality of cutting elements carried by the balloon.
- the plurality of cutting elements can be arranged collinearly and carried by the balloon.
- the device can include two adjacent cutting elements arranged overlapping relative to a longitudinal direction of the balloon.
- the cutting element can have a cutting edge with a radius of curvature less than about
- nanometers e.g., less than about 20 nanometers, or less than about 10 nanometers.
- the balloon can be smaller than a 10 French balloon, e.g., smaller than a 7 French, 5
- the invention features a medical device including an inflatable balloon, and a cutting element carried by the balloon.
- the cutting element has a hardness greater than about 5,700 kg/mm 2 .
- the cutting element can include diamond.
- the balloon can be smaller than a 10 French balloon, e.g., a 7 French, 5 French, or 3 French balloon.
- the invention features a medical device including an inflatable balloon smaller than a 10 French balloon, and a cutting element carried by the balloon.
- the cutting element can include diamond.
- the balloon can be smaller than a 10 French balloon, e.g., a 7 French, 5 French, or 3 French balloon.
- the invention features a method of using a medical device.
- the method includes providing the device having an inflatable balloon, a cutting element carried by the balloon, and a deformable member different than the balloon, the member being disposed over the cutting element, and expanding the balloon, the cutting element piercing the deformable member.
- the cutting element can have a cutting edge, and the method further includes radially reducing the balloon, the deformable member covering the cutting edge.
- the cutting element can pierce through the deformable member as the deformable member is contacted against a vessel wall.
- the invention features an endoprosthesis including an expandable tubular member, and a cutting element disposed on the tubular member.
- Embodiments can include one or more of the following features.
- the cutting element includes diamond.
- the cutting element includes a material having a hardness greater than about 5,700 kg/mm 2 .
- the cutting element has a cutting edge with a radius of curvature of less than about 50 nanometers.
- the cutting element has a cutting edge, and the stent further comprises a deformable member extending over the cutting edge.
- the endoprosthesis further includes a polymeric layer over a portion of the tubular member.
- the endoprosthesis further includes a drug-releasing layer over a portion of the tubular member.
- the endoprosthesis includes a plurality of cutting elements disposed on the tubular member.
- the tubular member is balloon-expandable or self-expandable.
- Embodiments may include one or more of the following advantages.
- the cutting element can be formed relatively sharp, and as a result, can provide well-defined, regular cuts with relatively low forces. Reducing random, uncontrolled cracking can reduce inflammation and/or restenosis of a body vessel.
- the cutting element can be formed relatively thin and flexible, e.g., without compromising strength. As a result, the cutting element can be supported by relatively small medical devices, such as catheters and stents, that are capable of being delivered through tortuous and narrow body lumens.
- the cutting element is biocompatible.
- the cutting element is compatible with magnetic resonance imaging (MRI).
- Endoprostheses having cutting elements can provide the cutting action of a cutting balloon and the expansion of an endoprosthesis in one step, which can be convenient and save time.
- FIG. 1 is an illustration of an embodiment of a medical device.
- Fig. 2 A is a cross sectional view of the medical device of Fig. 1, taken along line 2-2; and Fig. 2B is a detailed view of a portion of Fig. 2 A.
- Figs. 3A, 3B, and 3C illustrate an embodiment of a method of using the medical device of Fig. 1.
- Figs. 4A, 4B, and 4C are cross sectional views of the medical device shown in Figs.
- Fig. 5 is a schematic plan view of an embodiment of a medical device.
- Fig. 6 is a schematic plan view of an embodiment of a medical device.
- Fig. 7 is a cross sectional view of an embodiment of a medical device.
- Fig. 8 is a cross sectional view of an embodiment of a medical device.
- Fig. 9 is a cross sectional view of an embodiment of a medical device.
- Fig. 10 is a perspective view of an embodiment of a medical device.
- a balloon catheter 20 includes a catheter body 22, an inflatable balloon 24 attached to the catheter body, and one or more cutting elements 26, or atherotomes, (here, two) carried by the balloon.
- cutting element 26 is supported by a base 32 (e.g., by an adhesive) that is secured to balloon 24, for example, by an adhesive such as a urethane.
- Cutting element 26 includes a cutting edge 28, which is covered by a resilient material 30.
- Resilient material 30 can protect balloon 24 from the cutting edge and/or protect a vessel wall from the cutting edge, e.g., during insertion and withdrawal of catheter 20.
- cutting edge 28 can pierce through resilient material 30, thereby allowing cutting element 26 to cut, for example, plaque or a calcified material that is occluding a body vessel.
- Cutting elements 26 are elongated members (e.g., blades) preferably formed of diamond. Because of its physical properties, diamond enhances cutting element 26 by allowing cutting edge 28 to be formed with relatively high sharpness. A sharp cutting edge typically lowers the forces needed for cutting. Lower cutting forces can provide a relatively controlled, precise cut with enhanced regularity and less distortion, thereby reducing the occurrence of damage to the vessel wall. Sharpness can be measured as a radius of curvature of cutting edge 28, e.g., using scanning electron microscopy (SEM). In embodiments, cutting edge 28 has a radius of curvature less than about 50 nanometers.
- SEM scanning electron microscopy
- the radius of curvature can be equal to or less than about 50, 40, 30, 20, 10, 5, or 3 nanometers; and/or equal to or greater than about 3, 5, 10, 20, 30, or 40 nanometers.
- two or more of the cutting elements can have the same or different sharpness. Different sharpness can provide different degrees of cutting.
- a cutting element formed of diamond can also be relatively hard, and have a small friction coefficient and a small thermal expansion coefficient.
- cutting element 26 has a hardness of greater than or equal to about 4,000 kg/mm , e.g., between about 5,700-19,400 kg/mm 2 (Knoops hardness at 298K), and/or an elongation modulus of greater than or equal to about 1,140 GPa.
- the enhanced hardness allows cutting element 26 to be formed relatively thin, e.g., without compromising strength.
- cutting element 26 can be relatively flexible. Enhanced flexibility allows cutting element 26 to travel well through tortuous paths of a body vessel or passageway.
- cutting element 26 has a width (W, Fig.
- cutting element 26 less than or equal to about 0.006 inch, e.g., less than or equal to about 0.005 inch, 0.004 inch, 0.003 inch, 0.002 inch, or 0.001 inch.
- the length of cutting element 26 can be about 1-30 mm, e.g., about 5-20 mm, or about 10-15 mm.
- the height (H, Fig. 2B) of cutting element 26 can be less than or equal to about 0.013 inch, e.g., less than or equal to about 0.011 inch, 0.009 inch, 0.007 inch, or 0.005 inch.
- the dimensions of cutting element 26 typically are a function of the size of balloon catheter 20 that carries the cutting element(s). In embodiments of catheter 20 having multiple cutting elements 26, two or more of the cutting elements can have the same or different dimensions. Different dimensions can provide different degrees of cutting and/or flexibility. [0034] In some embodiments, only a portion of cutting element 26 is formed of diamond.
- a diamond member defining a cutting edge can be attached (e.g., glued) to a support, such as a metal (e.g., steel or Nitinol), ceramic, or polymer support, carried by the balloon.
- a support such as a Nitinol or polymer support, can be flexible, which can enhance the flexibility of the balloon.
- the diamond member can be made relatively small, e.g., smaller relative to the dimensions described above. One or more of the total dimensions of the diamond member and the support can be generally as described above.
- balloon catheter 20 is a 10 French device or smaller.
- balloon catheter 20 can be equal to smaller than a 9 French, 8 French, 7 French, 6 French (2.00 mm O.D.), 5 French, 4 French, 3 French, 2 French, or 1 French (1.00 mm O.D.) device.
- catheter 20 can be delivered to relatively narrow target sites, such as coronary arteries (e.g., those having a diameter less than about 2 mm), cranial arteries, and peripheral arteries (e.g., those in the lower extremities).
- Diamond cutting elements 26 are commercially available from GFD Deutschen fur
- Diamant area mbH (Ulm, Germany), which uses a plasma polishing process.
- Methods of making diamond cutting tools are described in U.S. Patent No. 4,989,578, and methods of polishing diamond is described in U.S. Patent No. 6,284,315.
- Resilient material 30 can be made of any material that can deform upon compression.
- Resilient material 30 can be made of a polymer, such as a rubber (e.g., a silicone rubber) or a soft polyurethane (e.g., Tecothane 55D). Resilient material 30 can be covered with a coating, such as a hydrophilic coating, to reduce friction.
- a polymer such as a rubber (e.g., a silicone rubber) or a soft polyurethane (e.g., Tecothane 55D).
- Resilient material 30 can be covered with a coating, such as a hydrophilic coating, to reduce friction.
- suitable materials include a hydrogel layer having a hydrophilic polymeric material such as (alkoxy) polyalkylene glycol, a copolymer of methylvinyl ether and maleic acid, poly(vinylpyrrolidone) (PNP), poly( ⁇ -alkylacrylamide), poly( acrylic acid), poly(vinyl alcohol), poly(ethyleneimine), polyamide, (carboxy)methyl cellulose, polyvinyl sulfonic acid, heparin, dextran, modified dextran and chondroitin sulfate, polyethylene oxide, poly(vinyl pyrrolidone), or a PNP/vinyl acetate copolymer.
- a hydrophilic polymeric material such as (alkoxy) polyalkylene glycol, a copolymer of methylvinyl ether and maleic acid, poly(vinylpyrrolidone) (PNP), poly( ⁇ -alkylacrylamide), poly( acrylic acid), poly(vinyl alcohol), poly
- Base 32 can be any material that is compatible, e.g., can be bonded with, balloon 24, cutting element 26, the adhesive, and/or resilient member 30.
- the material for base 32 can be relatively hard to provide a rigid support for cutting element 26, particularly during cutting, and to spread the cutting force from the cutting element to a larger area on balloon 24.
- base 32 can be formed of a metal (such as stainless steel, tantalum, tungsten, Nitinol, titanium, or niobium) anchored or molded to balloon 24, or a polymer (such as a polyimide or a polyamide, e.g., Nylon 12).
- Base 32 is MRI compatible, such as Nitinol, titanium, or niobium.
- Base 32 can be generally triangular, as shown, or non-triangular, e.g., rectangular, rhomboid, or trapezoid.
- balloon catheter 20 examples are described in, for example, Wang U.S. 5,195,969, and Hamlin U.S. 5,270,086, both hereby incorporated by reference; and are exemplified by the Express® or Maverick® systems available from Boston Scientific Scimed, Maple Grove, MN.
- balloon 24 is a non-elastic balloon, e.g., a nondistendable balloon made of, e.g., PET.
- Balloon 24 can include one or more biaxially-oriented layers.
- a target site 51 e.g., one having a calcified region 50
- Balloon 24 is unexpanded, and cutting edge 28 is covered by resilient material 30 to prevent the cutting edge from contacting vessel wall 52 (Fig. 4A).
- balloon 24 is radially expanded (arrows A), e.g., by introducing a fluid into the interior of the balloon via an inflation lumen (not shown) extending along catheter body 22.
- resilient material 30 and cutting element 26 are advanced radially toward calcified region 50.
- a drug or therapeutic agent e.g., heparin
- heparin is placed or encapsulated between resilient material 30 and cutting element 26.
- the drug or agent is released into a cutting area as edge 28 penetrates through resilient material 30 during use.
- Examples of drugs and therapeutic agents are disclosed in U.S. Patent No. 5,674,242; U.S.S.N. 09/895,415, filed July 2, 2001; and U.S.S.N. 10/232,265, filed August 30, 2002.
- the therapeutic agents or pharmaceutically active compounds can include, for example, anti- thrombogenic agents, antioxidants, anti-inflammatory agents, anesthetic agents, anticoagulants, and antibiotics.
- a sponge coating can be placed on balloon 24 or an endoprosthesis (described below).
- the sponge coating e.g., a non-hydrogel polymer having voids
- a drug e.g., heparin
- Examples of sponge coatings, including methods of making them, and suitable drugs, are described in U.S. Patent No., 6,364,856.
- catheter 20 is shown having two cutting elements 26, in other embodiments, the catheter can have one, three, four, five, six, seven, eight, or more cutting elements.
- Cutting elements 26 can be equally and/or unequally spaced around the circumference of balloon 24. For example, looking at a radial cross section (e.g., Fig. 4A) of a balloon having six cutting elements 26, the cutting elements can be formed at 2 o'clock, 3 o'clock, 4 o'clock, 8 o'clock, 9 o'clock, and 10 o'clock.
- Cutting element 26 at 3 o'clock is equally spaced from the cutting elements at 3 o'clock and 4 o'clock; but, for example, the cutting element at 4 o'clock is unequally spaced from the cutting elements at 3 o'clock and 8 o'clock.
- Cutting elements 26 can be symmetrically or asymmetrically positioned around the circumference of balloon 24.
- Multiple cutting elements 26, e.g., two, three, four, five, six, or more, can be arranged collinearly (e.g., spaced and end-to-end) along balloon 24 (Fig. 5), which can enhance the flexibility of the balloon.
- Multiple cutting elements 26 can be arranged side-by-side, e.g., adjacent to each other.
- Multiple cutting elements 26 can be arranged adjacent to each other and overlapping along the longitudinal direction of balloon 24 (Fig. 6).
- a balloon can have one or more sets of cutting elements arranged as described above.
- Other methods of attaching cutting elements 26 to balloon 24 are possible.
- Cutting elements 26 can be thermally and/or mechanically bonded.
- cutting elements 26 can include projections, e.g., hooks, at their base that embed into the wall of balloon 24.
- the projections can be embedded manually.
- the cutting elements can be appropriately positioned in the balloon- forming mold with the projections extending into the cavity of the mold.
- the projections are embedded into the wall of the balloon as a parison or a tube is radially expanded (e.g., blow molded) to form the balloon.
- Cutting element 26 may include one or more openings through which the material of base 32 can extend, thereby further securing the cutting element to the base.
- Cutting element(s) 26 can be attached directly to balloon 24, e.g., without base 32.
- cutting element can be elongated blades having a triangular cross section in which the base is attached to the balloon and the cutting edge is formed at the apex of the triangular section (Fig. 5).
- balloon 24 can be folded (Fig. 7) using the methods described in Vigil U.S. 5,209,799 and 5,336,234, both hereby incorporated by reference, to protect cutting elements 26.
- relatively compliant areas of balloon 24, e.g., flaps 60 can be folded over cutting elements 26 to further protect the body lumen from cutting edges 28. Folding can be performed by engaging, e.g., grasping, flaps 60 with a chuck, and rotating the chuck. Folding can be performed during heat treatment of balloon 24, as described in Vigil U.S. 5,209,799. Other methods of folding balloon 24 are described in U.S.S.N. 10/087,303.
- balloon 24 and/or catheter body 22 can have a wall having a plurality of layers formed of polymers.
- Multilayer devices are described in Hamlin U.S. 5,270,086; Wang U.S. 5,195,969; Hamilton U.S. 5,797,877; and U.S.S.N. 09/798,749, entitled “Multilayer Medical Device” and filed on March 2, 2001, all hereby incorporated by reference in their entirety.
- the layers can be selected to provide catheter body 22 and/or balloon 24 with desired properties. Different combinations of layering, e.g., materials, sequence, and/or thickness, can be used, as described in U.S.S.N. 09/798,749.
- balloon 24 can be co-extruded to include a matrix material 62 and discrete (e.g., individually distinct) striped portions 64 (here, four) surrounded by the matrix material.
- Cutting elements 26 are attached to balloon 24 over striped portions 64.
- striped portions 64 are formed of a material(s) having a lower compliancy than material(s) that are not in the striped portions, such as those of matrix material 62.
- striped portions 64 are formed of a material(s) having a lower distensibility than material(s) that are not in the striped portions. Compliancy and distensibility may apply to the radial direction and/or the longitudinal direction of balloon 24.
- striped portions 64 are stiffer, harder, and/or stronger than non-striped portions of balloon 24.
- Attaching cutting elements 26 over striped portions 64 enhances the attachment between the cutting elements and balloon 24.
- balloon 24 is inflated (e.g., up to 10 atm or higher) and deflated during use, striped portions 64 are less likely to change, e.g., grow or distend, longitudinally and/or radially, relative to non-striped portions of the balloon, such as compliant portions made of the matrix material.
- the interface between cutting elements 26 and striped portions 64 can remain relatively constant during use. As a result, mechanical stress between cutting elements 26 and balloon 24 reduced, and attachment therebetween is enhanced.
- Striped portions 64 can also enhance folding and refolding of balloon 24.
- a striped portion 64 and areas adjacent to the striped portions can behave like a hinge.
- a (relatively non-compliant) striped portion 62 can act as a stationary member of a hinge and the (relatively compliant) adjacent areas can act as moveable members of the hinge that pivot about the interfacial region between the striped portion and the adjacent areas.
- balloon 24 When balloon 24 is deflated, it can fold along the interfacial region so that compliant areas form flaps, and striped portions 64 are positioned in furrows.
- balloon 24 can be formed and used with a relatively low profile and a relatively predictable folding configuration, thereby providing desirable insertion and withdrawal of catheter 20 from a subject.
- Embodiments of balloon 24 and stripes portions 64 are described in U.S.S.N. 10/083,926, entitled “Medical Device” and filed on February 27, 2002, hereby incorporated by reference.
- Cutting element(s) 26 can be attached directly to the balloon or indirectly, e.g., through base 32.
- one or more cutting elements 26 can be carried by an endoprosthesis 70, such as a stent or a stent-graft, here shown on a support such as a balloon catheter or a catheter shaft 72. As shown, cutting elements 26 are mounted on the struts of endoprosthesis 70. During expansion, cutting elements 26 can cut a calcified region, which can reduce the amount of force used to expand endoprosthesis. Cutting elements 26 can be mounted on endoprosthesis 70 using a biocompatible adhesive or cement, such as DiamondLinkTM (available from Biodent, Quebec, Canada).
- a biocompatible adhesive or cement such as DiamondLinkTM (available from Biodent, Quebec, Canada).
- Embodiments of the cutting elements on endoprosthesis 70 can be the same as those described above, and can be arranged on the endoprosthesis the same as those on balloon 24.
- the cutting elements on endoprosthesis 70 can be sprayed with a polymer, such as styrene-isobutylene-styrene (SIBS, a tri-blocked polymer) to protect the cutting edges, e.g., during delivery and/or crimping.
- SIBS styrene-isobutylene-styrene
- a drug or therapeutic agent e.g., placitaxel or those described above
- the drug can be released to a cutting site as endoprosthesis 70 is expanded and cutting elements 26 penetrate the site.
- a soft polymer tube e.g., one thicker than the cutting elements
- the tube can distribute the crimping force over a broad area of endoprosthesis 70, thereby reducing damage to the cutting elements.
- the polymer e.g., SIBS
- SIBS can be applied to the cutting elements after crimping.
- the polymer can be applied to cutting elements 26 on balloon 24.
- the endoprostheses can be of any desired shape and size (e.g., coronary stents, aortic stents, peripheral stents, gastrointestinal stents, urology stents and neurology stents).
- a coronary stent can have an expanded diameter of from about 2 millimeters to about 6 millimeters.
- a peripheral stent can have an expanded diameter of from about 5 millimeters to about 24 millimeters.
- a gastrointestinal and/or urology stent can have an expanded diameter of from about 6 millimeters to about 30 millimeters.
- a neurology stent can have an expanded diameter of from about 1 millimeter to about 12 millimeters.
- the endoprostheses can be balloon-expandable, self-expandable, or a combination of both (e.g., U.S. Patent No. 5,366,504).
- the endoprosthesis can include and/or be attached to a biocompatible, non-porous or semi-porous polymer matrix made of polytetrafluoroethylene
- the endoprosthesis can include a releasable therapeutic agent or a pharmaceutically active compound, such as described in U.S. Patent No. 5,674,242, and commonly assigned U.S.S.N. 09/895,415, filed July 2, 2001.
- the therapeutic agents or pharmaceutically active compounds can include, for example, anti-thrombogenic agents, antioxidants, anti-inflammatory agents, anesthetic agents, anti-coagulants, and antibiotics.
- the endoprosthesis can be used, e.g., delivered and expanded, according to conventional methods.
- Suitable catheter systems are described in, for example, Wang U.S. 5,195,969, and Hamlin U.S. 5,270,086.
- Suitable stents and stent delivery are also exemplified by the NIR on Ranger® system, available from Boston Scientific Scimed, Maple Grove, MN.
- Other methods of carrying and delivering an endoprosthesis is described in U.S.S.N. 10/283,815, filed October 30, 2002, and entitled "Medical Devices With Magnetic Powered Actuation".
- the medical devices described above can include radiopaque markers and/or markers that are visible by magnetic resonance imaging (MRI)) portions or markers to help the user position the devices.
- MRI magnetic resonance imaging
- a portion of cutting element 26 can be coated with a radiopaque and/or MRI visible material; balloon 24 may include one or more marker bands; and the wire of the stent or stent-graft can be radiopaque and/or MRI visible.
- Suitable radiopaque materials include, for example, gold, platinum, tungsten, tantalum, and metal alloys containing a sufficient percentage of heavy elements.
- Suitable MRI visible materials include, for example, non-ferrous metal-alloys containing paramagnetic elements (e.g., dysprosium or gadolinium) such as terbium-dysprosium, dysprosium, terbium, and gadolinium; non-ferrous metallic bands coated with an oxide or a carbide layer of dysprosium or gadolinium (e.g., Dy 2 O 3 or Gd 2 O 3 ); non-ferrous metals (e.g., copper, silver, platinum, or gold) coated with a layer of superparamagnetic material, such as nanocrystallme Fe 3 O 4 , CoFe 2 O 4 , MnFe O 4 , or MgFe 2 O 4 ; and nanocrystallme particles of the transition metal oxides (e.g., oxides of Fe, Co, Ni).
- non-ferrous metal-alloys containing paramagnetic elements e.g., dysprosium or gadolinium
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT03812090T ATE457688T1 (en) | 2003-01-02 | 2003-12-30 | MEDICAL BALLOON WITH CUTTING TOOL |
EP03812090A EP1587427B1 (en) | 2003-01-02 | 2003-12-30 | Medical balloon with cutting elements |
AU2003302771A AU2003302771A1 (en) | 2003-01-02 | 2003-12-30 | Medical devices with cutting element. |
DE60331363T DE60331363D1 (en) | 2003-01-02 | 2003-12-30 | Medical balloon with cutting tool |
CA002512172A CA2512172A1 (en) | 2003-01-02 | 2003-12-30 | Medical devices |
JP2004564960A JP4566752B2 (en) | 2003-01-02 | 2003-12-30 | Medical instruments |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/335,604 US7494497B2 (en) | 2003-01-02 | 2003-01-02 | Medical devices |
US10/335,604 | 2003-01-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004060460A2 true WO2004060460A2 (en) | 2004-07-22 |
WO2004060460A3 WO2004060460A3 (en) | 2004-11-11 |
Family
ID=32680843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/041852 WO2004060460A2 (en) | 2003-01-02 | 2003-12-30 | Medical devices with cutting element. |
Country Status (8)
Country | Link |
---|---|
US (1) | US7494497B2 (en) |
EP (3) | EP1941839A3 (en) |
JP (1) | JP4566752B2 (en) |
AT (2) | ATE457688T1 (en) |
AU (1) | AU2003302771A1 (en) |
CA (1) | CA2512172A1 (en) |
DE (2) | DE60331363D1 (en) |
WO (1) | WO2004060460A2 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004066852A2 (en) | 2003-01-21 | 2004-08-12 | Angioscore Inc. | Apparatus for treating hardened vascular lesions |
WO2005060840A1 (en) * | 2003-12-01 | 2005-07-07 | Boston Scientific Limited | Cutting balloon having sheathed incising elements |
EP1611920A1 (en) * | 2003-03-10 | 2006-01-04 | Kaneka Corporation | Stent |
WO2006073933A2 (en) * | 2004-12-30 | 2006-07-13 | Cook Incorporated | Catheter assembly with plaque cutting balloon |
JP2008509749A (en) * | 2004-08-13 | 2008-04-03 | アンジオスコア, インコーポレイテッド | Method and apparatus for manipulating a vascular prosthesis |
JP2009514632A (en) * | 2005-11-10 | 2009-04-09 | ギュンテル・ファリン | Apparatus and method for shortening and / or fragmenting a stent placed in a hollow organ by endoscopic control |
WO2009114425A1 (en) * | 2008-03-13 | 2009-09-17 | Cook Incorporated | Cutting balloon with connector and dilation element |
US7708753B2 (en) | 2005-09-27 | 2010-05-04 | Cook Incorporated | Balloon catheter with extendable dilation wire |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
WO2014163955A1 (en) | 2013-03-13 | 2014-10-09 | The Spectranetics Corporation | Assisted cutting balloon |
US9173977B2 (en) | 2010-04-19 | 2015-11-03 | Angioscore, Inc. | Coating formulations for scoring or cutting balloon catheters |
US9351756B2 (en) | 2010-09-21 | 2016-05-31 | Angioscore, Inc. | Method and system for treating valve stenosis |
US9375328B2 (en) | 2001-11-09 | 2016-06-28 | Angioscore, Inc. | Balloon catheter with non-deployable stent |
US9586031B2 (en) | 2005-05-11 | 2017-03-07 | Angioscore, Inc. | Methods and systems for delivering substances into luminal walls |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US10086178B2 (en) | 2001-11-09 | 2018-10-02 | Angioscore, Inc. | Balloon catheter with non-deployable stent |
US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
US10201387B2 (en) | 2013-03-13 | 2019-02-12 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10286190B2 (en) | 2013-12-11 | 2019-05-14 | Cook Medical Technologies Llc | Balloon catheter with dynamic vessel engaging member |
US10842567B2 (en) | 2013-03-13 | 2020-11-24 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10850078B2 (en) | 2014-12-30 | 2020-12-01 | The Spectranetics Corporation | Electrically-induced fluid filled balloon catheter |
US10898213B2 (en) | 2014-12-30 | 2021-01-26 | The Spectranetics Corporation | Electrically-induced pressure wave emitting catheter sheath |
US11058492B2 (en) | 2014-12-30 | 2021-07-13 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US11246659B2 (en) | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
Families Citing this family (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7279002B2 (en) * | 2003-04-25 | 2007-10-09 | Boston Scientific Scimed, Inc. | Cutting stent and balloon |
US8876882B2 (en) * | 2003-10-10 | 2014-11-04 | Mark Gelido Barongan | Cutting stent |
US7329383B2 (en) * | 2003-10-22 | 2008-02-12 | Boston Scientific Scimed, Inc. | Alloy compositions and devices including the compositions |
US8048093B2 (en) * | 2003-12-19 | 2011-11-01 | Boston Scientific Scimed, Inc. | Textured balloons |
US7338463B2 (en) * | 2003-12-19 | 2008-03-04 | Boston Scientific Scimed, Inc. | Balloon blade sheath |
US8623067B2 (en) * | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
CA2758946C (en) | 2004-05-25 | 2014-10-21 | Tyco Healthcare Group Lp | Vascular stenting for aneurysms |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
JP2008502378A (en) | 2004-05-25 | 2008-01-31 | チェストナット メディカル テクノロジーズ インコーポレイテッド | Flexible vascular closure device |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US9675476B2 (en) | 2004-05-25 | 2017-06-13 | Covidien Lp | Vascular stenting for aneurysms |
US7976557B2 (en) | 2004-06-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Cutting balloon and process |
US8500797B2 (en) * | 2004-09-08 | 2013-08-06 | Boston Scientific Scimed, Inc. | Medical devices |
US7722578B2 (en) * | 2004-09-08 | 2010-05-25 | Boston Scientific Scimed, Inc. | Medical devices |
US8038691B2 (en) * | 2004-11-12 | 2011-10-18 | Boston Scientific Scimed, Inc. | Cutting balloon catheter having flexible atherotomes |
US7291158B2 (en) * | 2004-11-12 | 2007-11-06 | Boston Scientific Scimed, Inc. | Cutting balloon catheter having a segmented blade |
US20060178685A1 (en) * | 2004-12-30 | 2006-08-10 | Cook Incorporated | Balloon expandable plaque cutting device |
US7850645B2 (en) * | 2005-02-11 | 2010-12-14 | Boston Scientific Scimed, Inc. | Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power |
US8048028B2 (en) * | 2005-02-17 | 2011-11-01 | Boston Scientific Scimed, Inc. | Reinforced medical balloon |
US20060182873A1 (en) * | 2005-02-17 | 2006-08-17 | Klisch Leo M | Medical devices |
US20060247674A1 (en) * | 2005-04-29 | 2006-11-02 | Roman Ricardo D | String cutting balloon |
US7691082B2 (en) * | 2005-07-01 | 2010-04-06 | Boston Scientific Scimed, Inc. | Medical devices |
US8034066B2 (en) * | 2005-09-15 | 2011-10-11 | Boston Scientific Scimed, Inc. | Multi-layer medical balloons |
US20070112300A1 (en) * | 2005-11-14 | 2007-05-17 | Roman Ricardo D | Balloon folding design, apparatus and method of making the same |
US20080004689A1 (en) * | 2006-01-19 | 2008-01-03 | Linda Jahnke | Systems and Methods for Making Medical Devices |
US8152833B2 (en) | 2006-02-22 | 2012-04-10 | Tyco Healthcare Group Lp | Embolic protection systems having radiopaque filter mesh |
US20080077165A1 (en) * | 2006-02-24 | 2008-03-27 | National University Of Ireland, Galway | Minimally Invasive Intravascular Treatment Device |
US20080077164A1 (en) * | 2006-02-24 | 2008-03-27 | National University Of Ireland, Galway | Minimally Invasive Intravascular Treatment Device |
EP1825824B1 (en) * | 2006-02-24 | 2009-11-04 | National University of Ireland, Galway | Minimally invasive intravascular treatment device |
US7691116B2 (en) * | 2006-03-09 | 2010-04-06 | Boston Scientific Scimed, Inc. | Cutting blade for medical devices |
US20070244501A1 (en) * | 2006-04-18 | 2007-10-18 | Horn Daniel J | Medical balloons |
WO2007139799A2 (en) * | 2006-05-24 | 2007-12-06 | Mayo Foundation For Medical Education And Research | Devices and methods for crossing chronic total occlusions |
JP2008000276A (en) * | 2006-06-21 | 2008-01-10 | Kaneka Corp | Expansion body of catheter and expansion catheter |
CN102258811B (en) * | 2006-07-03 | 2015-03-11 | 汉莫堤克股份有限公司 | Manufacture, method and use of active substance-releasing medical products for permanently keeping blood vessels open |
US8153181B2 (en) * | 2006-11-14 | 2012-04-10 | Boston Scientific Scimed, Inc. | Medical devices and related methods |
EP2491962A1 (en) * | 2007-01-21 | 2012-08-29 | Hemoteq AG | Medical product for treating closures of bodily passages and preventing reclosures |
US8540674B2 (en) | 2007-04-27 | 2013-09-24 | Cvdevices, Llc | Devices, systems, and methods for transeptal atrial puncture using an engagement catheter platform |
US9050064B2 (en) * | 2007-04-27 | 2015-06-09 | Cvdevices, Llc | Systems for engaging a bodily tissue and methods of using the same |
US20080300610A1 (en) * | 2007-05-31 | 2008-12-04 | Cook Incorporated | Device for treating hardened lesions and method of use thereof |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US9192697B2 (en) * | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
US20090105687A1 (en) * | 2007-10-05 | 2009-04-23 | Angioscore, Inc. | Scoring catheter with drug delivery membrane |
US8936567B2 (en) | 2007-11-14 | 2015-01-20 | Boston Scientific Scimed, Inc. | Balloon bifurcated lumen treatment |
US20090171284A1 (en) * | 2007-12-27 | 2009-07-02 | Cook Incorporated | Dilation system |
EP2300093B1 (en) | 2008-06-05 | 2016-04-20 | Boston Scientific Scimed, Inc. | Deflatable bifurcated device |
EP2172242A1 (en) * | 2008-10-03 | 2010-04-07 | National University of Ireland Galway | Intravascular Treatment Device |
GB2469297B (en) | 2009-04-07 | 2011-05-25 | Cook Inc | Introducer assembly and implantable medical device |
US20100286593A1 (en) * | 2009-05-11 | 2010-11-11 | Hotspur Technologies, Inc. | Balloon catheter with cutting features and methods for use |
WO2011005421A2 (en) | 2009-07-10 | 2011-01-13 | Boston Scientific Scimed, Inc. | Use of nanocrystals for a drug delivery balloon |
EP2453938B1 (en) | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
US9277935B2 (en) | 2009-08-13 | 2016-03-08 | Quadra Endovascular, Inc. | Temporary vascular scaffold and scoring device |
US8764705B2 (en) | 2010-05-07 | 2014-07-01 | Cook Medical Technologies Llc | Balloon with integral segmented dilation elements |
US8211354B2 (en) * | 2010-05-18 | 2012-07-03 | Cook Medical Technologies Llc | Balloon with integral retention of a dilation element |
WO2012031236A1 (en) | 2010-09-02 | 2012-03-08 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
JP5694718B2 (en) * | 2010-09-27 | 2015-04-01 | テルモ株式会社 | Stent graft system for delivering a stent graft into the body |
US9282991B2 (en) | 2010-10-06 | 2016-03-15 | Rex Medical, L.P. | Cutting wire assembly with coating for use with a catheter |
US8685050B2 (en) | 2010-10-06 | 2014-04-01 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
AU2011226821B2 (en) * | 2010-10-06 | 2015-09-17 | Rex Medical, L.P. | Cutting wire assembly for use with a catheter |
US8685049B2 (en) | 2010-11-18 | 2014-04-01 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
US8702736B2 (en) | 2010-11-22 | 2014-04-22 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
US8491615B2 (en) | 2010-12-29 | 2013-07-23 | Boston Scientific Scimed, Inc. | Cutting balloon catheter |
GB2487400B (en) * | 2011-01-20 | 2013-07-10 | Cook Medical Technologies Llc | Scoring balloon with offset scoring elements |
US20120316589A1 (en) * | 2011-06-07 | 2012-12-13 | Cook Medical Technologies Llc | Balloon catheter with raised elements and visual marker |
WO2013022458A1 (en) | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
WO2013038013A1 (en) * | 2011-09-16 | 2013-03-21 | Syntach Ag | A device, and a method for treatment of increased blood pressure |
US9302079B2 (en) * | 2011-12-02 | 2016-04-05 | Cook Medical Technologies Llc | Integral dilation element for a balloon catheter |
US9408671B2 (en) | 2011-12-08 | 2016-08-09 | Parker Laboratories, Inc. | Biopsy grid |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
EP2749310A1 (en) | 2012-12-28 | 2014-07-02 | Cook Medical Technologies LLC | Ureteral endoluminal device |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
CA2871300A1 (en) * | 2013-11-29 | 2015-05-29 | Cook Medical Technologies Llc | Medical balloon |
CN103877672B (en) * | 2014-03-27 | 2016-08-17 | 北京工业大学 | A kind of double blade Cutting balloon of uneven gauge |
WO2015161211A1 (en) * | 2014-04-17 | 2015-10-22 | Boston Scientific Scimed, Inc. | Devices and methods for therapeutic heat treatment |
EP3226783B1 (en) | 2014-12-03 | 2024-01-10 | PAVmed Inc. | Systems for percutaneous division of fibrous structures |
US10182841B1 (en) * | 2015-06-16 | 2019-01-22 | C.R. Bard, Inc. | Medical balloon with enhanced focused force control |
EP3799919A1 (en) * | 2015-09-17 | 2021-04-07 | Cagent Vascular, LLC | Wedge dissectors for a medical ballon |
US10314593B2 (en) | 2015-09-23 | 2019-06-11 | Covidien Lp | Occlusive devices |
US10661092B2 (en) | 2015-10-07 | 2020-05-26 | Boston Scientific Scimed, Inc. | Mixture of lafesih magnetic nanoparticles with different curie temperatures for improved inductive heating efficiency for hyperthermia therapy |
CN108697434B (en) * | 2016-02-15 | 2021-11-19 | 泰尔茂株式会社 | Medical instrument |
ES2954170T3 (en) * | 2016-05-26 | 2023-11-20 | Goodman Co Ltd | Balloon catheter and balloon body manufacturing procedure |
JP2019146599A (en) * | 2016-07-11 | 2019-09-05 | テルモ株式会社 | Balloon catheter |
JP6963554B2 (en) * | 2016-08-23 | 2021-11-10 | テルモ株式会社 | Medical device |
WO2018060466A1 (en) * | 2016-09-30 | 2018-04-05 | Arravasc Limited | Finned angioplasty balloon |
JP6836894B2 (en) * | 2016-12-22 | 2021-03-03 | テルモ株式会社 | Medical device |
JP6769905B2 (en) * | 2017-03-30 | 2020-10-14 | テルモ株式会社 | Medical long body |
JP6804370B2 (en) * | 2017-03-31 | 2020-12-23 | テルモ株式会社 | Medical long body |
JP7356974B2 (en) * | 2017-10-27 | 2023-10-05 | トランジット サイエンティフィック,エルエルシー | Exoskeleton device with expandable part for scoring |
US11154320B2 (en) | 2018-04-09 | 2021-10-26 | Boston Scientific Scimed, Inc. | Cutting balloon basket |
JP6975857B2 (en) * | 2018-07-09 | 2021-12-01 | 株式会社グッドマン | Balloon catheter |
US11812987B2 (en) | 2019-11-27 | 2023-11-14 | Boston Scientific Scimed, Inc. | Cutting balloon catheter |
US12011184B2 (en) | 2020-02-10 | 2024-06-18 | Elixir Medical Corporation | Methods and apparatus for plaque disruption |
CN117015413A (en) * | 2021-06-22 | 2023-11-07 | 株式会社戈德曼 | Balloon body for catheter and balloon catheter |
AU2022298081A1 (en) * | 2021-06-22 | 2023-12-21 | Goodman Co., Ltd. | Balloon for catheter |
JP2024116669A (en) * | 2023-02-16 | 2024-08-28 | 株式会社東海メディカルプロダクツ | Balloons and balloon catheters |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616149A (en) * | 1990-07-03 | 1997-04-01 | Cedars-Sinai Medical Center | Balloon catheter with cutting edge |
US5713913A (en) * | 1996-11-12 | 1998-02-03 | Interventional Technologies Inc. | Device and method for transecting a coronary artery |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366504A (en) | 1992-05-20 | 1994-11-22 | Boston Scientific Corporation | Tubular medical prosthesis |
CA2087132A1 (en) | 1992-01-31 | 1993-08-01 | Michael S. Williams | Stent capable of attachment within a body lumen |
US5397355A (en) | 1994-07-19 | 1995-03-14 | Stentco, Inc. | Intraluminal stent |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5792158A (en) * | 1995-11-15 | 1998-08-11 | Lary; Banning Gray | University dilator with expandable incisor |
US5593417A (en) | 1995-11-27 | 1997-01-14 | Rhodes; Valentine J. | Intravascular stent with secure mounting means |
US6197013B1 (en) | 1996-11-06 | 2001-03-06 | Setagon, Inc. | Method and apparatus for drug and gene delivery |
US6015420A (en) * | 1997-03-06 | 2000-01-18 | Scimed Life Systems, Inc. | Atherectomy device for reducing damage to vessels and/or in-vivo stents |
US5902475A (en) * | 1997-04-08 | 1999-05-11 | Interventional Technologies, Inc. | Method for manufacturing a stent |
JP3691236B2 (en) * | 1998-01-23 | 2005-09-07 | 朝日インテック株式会社 | catheter |
US6364856B1 (en) | 1998-04-14 | 2002-04-02 | Boston Scientific Corporation | Medical device with sponge coating for controlled drug release |
DE10107795B4 (en) | 2001-02-13 | 2014-05-15 | Berlex Ag | Vascular support with a basic body, method for producing the vascular support, apparatus for coating the vascular support |
EP1415681A4 (en) * | 2001-08-08 | 2008-05-28 | Kaneka Corp | Expansion catheter |
US6632231B2 (en) * | 2001-08-23 | 2003-10-14 | Scimed Life Systems, Inc. | Segmented balloon catheter blade |
US7153315B2 (en) * | 2002-06-11 | 2006-12-26 | Boston Scientific Scimed, Inc. | Catheter balloon with ultrasonic microscalpel blades |
-
2003
- 2003-01-02 US US10/335,604 patent/US7494497B2/en not_active Expired - Fee Related
- 2003-12-30 JP JP2004564960A patent/JP4566752B2/en not_active Expired - Fee Related
- 2003-12-30 DE DE60331363T patent/DE60331363D1/en not_active Expired - Lifetime
- 2003-12-30 EP EP08154260A patent/EP1941839A3/en not_active Withdrawn
- 2003-12-30 AT AT03812090T patent/ATE457688T1/en not_active IP Right Cessation
- 2003-12-30 AU AU2003302771A patent/AU2003302771A1/en not_active Abandoned
- 2003-12-30 EP EP08154259A patent/EP1935376B1/en not_active Expired - Lifetime
- 2003-12-30 EP EP03812090A patent/EP1587427B1/en not_active Expired - Lifetime
- 2003-12-30 CA CA002512172A patent/CA2512172A1/en not_active Abandoned
- 2003-12-30 DE DE60335152T patent/DE60335152D1/en not_active Expired - Lifetime
- 2003-12-30 WO PCT/US2003/041852 patent/WO2004060460A2/en active Application Filing
- 2003-12-30 AT AT08154259T patent/ATE489056T1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616149A (en) * | 1990-07-03 | 1997-04-01 | Cedars-Sinai Medical Center | Balloon catheter with cutting edge |
US5713913A (en) * | 1996-11-12 | 1998-02-03 | Interventional Technologies Inc. | Device and method for transecting a coronary artery |
Non-Patent Citations (1)
Title |
---|
See also references of EP1587427A2 * |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10086178B2 (en) | 2001-11-09 | 2018-10-02 | Angioscore, Inc. | Balloon catheter with non-deployable stent |
US11571554B2 (en) | 2001-11-09 | 2023-02-07 | Angioscore, Inc. | Balloon catheter with non-deployable stent |
US9375328B2 (en) | 2001-11-09 | 2016-06-28 | Angioscore, Inc. | Balloon catheter with non-deployable stent |
US9962529B2 (en) | 2003-01-21 | 2018-05-08 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
WO2004066852A2 (en) | 2003-01-21 | 2004-08-12 | Angioscore Inc. | Apparatus for treating hardened vascular lesions |
US8454636B2 (en) | 2003-01-21 | 2013-06-04 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
EP1587428B1 (en) * | 2003-01-21 | 2018-12-05 | AngioScore, Inc. | Apparatus for treating hardened vascular lesions |
US10722694B2 (en) | 2003-01-21 | 2020-07-28 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US8721667B2 (en) | 2003-01-21 | 2014-05-13 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
EP1611920A4 (en) * | 2003-03-10 | 2007-01-24 | Kaneka Corp | Stent |
EP1611920A1 (en) * | 2003-03-10 | 2006-01-04 | Kaneka Corporation | Stent |
WO2005060840A1 (en) * | 2003-12-01 | 2005-07-07 | Boston Scientific Limited | Cutting balloon having sheathed incising elements |
US7799043B2 (en) | 2003-12-01 | 2010-09-21 | Boston Scientific Scimed, Inc. | Cutting balloon having sheathed incising elements |
JP2008509749A (en) * | 2004-08-13 | 2008-04-03 | アンジオスコア, インコーポレイテッド | Method and apparatus for manipulating a vascular prosthesis |
US7303572B2 (en) | 2004-12-30 | 2007-12-04 | Cook Incorporated | Catheter assembly with plaque cutting balloon |
JP4940398B2 (en) * | 2004-12-30 | 2012-05-30 | クック メディカル テクノロジーズ エルエルシー | Catheter assembly with plaque cutting balloon |
AU2005323017B2 (en) * | 2004-12-30 | 2010-12-02 | Cook Medical Technologies Llc | Catheter assembly with plaque cutting balloon |
JP2008526312A (en) * | 2004-12-30 | 2008-07-24 | クック インコーポレイテッド | Catheter assembly with plaque cutting balloon |
WO2006073933A3 (en) * | 2004-12-30 | 2006-09-08 | Cook Inc | Catheter assembly with plaque cutting balloon |
WO2006073933A2 (en) * | 2004-12-30 | 2006-07-13 | Cook Incorporated | Catheter assembly with plaque cutting balloon |
US11420030B2 (en) | 2005-05-11 | 2022-08-23 | Angioscore, Inc. | Methods and systems for delivering substances into luminal walls |
US10342960B2 (en) | 2005-05-11 | 2019-07-09 | Angioscore, Inc. | Methods and systems for delivering substances into luminal walls |
US9586031B2 (en) | 2005-05-11 | 2017-03-07 | Angioscore, Inc. | Methods and systems for delivering substances into luminal walls |
US7708753B2 (en) | 2005-09-27 | 2010-05-04 | Cook Incorporated | Balloon catheter with extendable dilation wire |
JP2009514632A (en) * | 2005-11-10 | 2009-04-09 | ギュンテル・ファリン | Apparatus and method for shortening and / or fragmenting a stent placed in a hollow organ by endoscopic control |
US9604036B2 (en) | 2008-03-13 | 2017-03-28 | Cook Medical Technologies Llc | Cutting balloon with connector and dilation element |
US10016212B2 (en) | 2008-03-13 | 2018-07-10 | Cook Medical Technologies Llc | Cutting balloon with connector and dilation element |
WO2009114425A1 (en) * | 2008-03-13 | 2009-09-17 | Cook Incorporated | Cutting balloon with connector and dilation element |
US10617443B2 (en) | 2008-03-13 | 2020-04-14 | Cook Medical Technologies Llc | Cutting balloon with connector and dilation element |
US10471184B2 (en) | 2010-04-19 | 2019-11-12 | Angioscore, Inc. | Coating formulations for scoring or cutting balloon catheters |
US9173977B2 (en) | 2010-04-19 | 2015-11-03 | Angioscore, Inc. | Coating formulations for scoring or cutting balloon catheters |
US10314947B2 (en) | 2010-04-19 | 2019-06-11 | Angioscore, Inc. | Coating formulations for scoring or cutting balloon catheters |
US10736652B2 (en) | 2010-09-21 | 2020-08-11 | Angioscore, Inc. | Method and system for treating valve stenosis |
US9364254B2 (en) | 2010-09-21 | 2016-06-14 | Angioscore, Inc. | Method and system for treating valve stenosis |
US9351756B2 (en) | 2010-09-21 | 2016-05-31 | Angioscore, Inc. | Method and system for treating valve stenosis |
US10842567B2 (en) | 2013-03-13 | 2020-11-24 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10201387B2 (en) | 2013-03-13 | 2019-02-12 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US10786661B2 (en) | 2013-03-13 | 2020-09-29 | The Spectranetics Corporation | Apparatus and method for balloon angioplasty |
EP3750490A1 (en) * | 2013-03-13 | 2020-12-16 | The Spectranetics Corporation | Assisted cutting balloon and catheter comprising the balloon |
EP2967609A4 (en) * | 2013-03-13 | 2016-09-07 | Spectranetics Corp | Assisted cutting balloon |
WO2014163955A1 (en) | 2013-03-13 | 2014-10-09 | The Spectranetics Corporation | Assisted cutting balloon |
US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
US10485571B2 (en) | 2013-10-08 | 2019-11-26 | Angioscore, Inc. | Balloon catheter with non-deployable stent having improved stability |
US10286190B2 (en) | 2013-12-11 | 2019-05-14 | Cook Medical Technologies Llc | Balloon catheter with dynamic vessel engaging member |
US9956384B2 (en) | 2014-01-24 | 2018-05-01 | Cook Medical Technologies Llc | Articulating balloon catheter and method for using the same |
US11246659B2 (en) | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
US10850078B2 (en) | 2014-12-30 | 2020-12-01 | The Spectranetics Corporation | Electrically-induced fluid filled balloon catheter |
US11058492B2 (en) | 2014-12-30 | 2021-07-13 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US10898213B2 (en) | 2014-12-30 | 2021-01-26 | The Spectranetics Corporation | Electrically-induced pressure wave emitting catheter sheath |
Also Published As
Publication number | Publication date |
---|---|
ATE489056T1 (en) | 2010-12-15 |
EP1941839A3 (en) | 2008-07-23 |
ATE457688T1 (en) | 2010-03-15 |
AU2003302771A8 (en) | 2004-07-29 |
WO2004060460A3 (en) | 2004-11-11 |
EP1941839A2 (en) | 2008-07-09 |
EP1935376A3 (en) | 2008-07-09 |
EP1587427A2 (en) | 2005-10-26 |
US7494497B2 (en) | 2009-02-24 |
EP1587427B1 (en) | 2010-02-17 |
CA2512172A1 (en) | 2004-07-22 |
US20040133223A1 (en) | 2004-07-08 |
DE60331363D1 (en) | 2010-04-01 |
DE60335152D1 (en) | 2011-01-05 |
EP1935376B1 (en) | 2010-11-24 |
EP1935376A2 (en) | 2008-06-25 |
JP4566752B2 (en) | 2010-10-20 |
AU2003302771A1 (en) | 2004-07-29 |
JP2006512952A (en) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1935376B1 (en) | Stent with cutting element | |
EP1441669B1 (en) | Baloon catheter with non-deployable stent | |
JP4361217B2 (en) | Balloon catheter and stent deployment catheter system | |
JP4279891B2 (en) | Method of manufacturing a system for treating a vascular condition | |
US6443979B1 (en) | Expandable stent delivery sheath and method of use | |
US7226473B2 (en) | Treatment of stenotic regions | |
US5634901A (en) | Method of using a catheter sleeve | |
JP2020114545A (en) | Medical device | |
US8529619B2 (en) | Methods for delivering a prosthesis to a site in a body | |
US6620191B1 (en) | System for releasably securing a stent on a catheter assembly and method of use | |
EP2833837B1 (en) | Devices for treating an aneurysm | |
US20050149163A1 (en) | Reduced restenosis drug containing stents | |
US20090112239A1 (en) | Sticky dilatation balloon and methods of using | |
US20110022152A1 (en) | Double layered balloons in medical devices | |
JP2004527285A (en) | Balloon catheter stent delivery system with ridge | |
JP2002537894A (en) | System for removably attaching a stent to a catheter assembly and method of use thereof | |
WO2009046206A1 (en) | Scoring catheter with drug delivery membrane | |
EP1885431A2 (en) | Methods and systems for delivering substances into luminal walls | |
EP1765223A2 (en) | Balloon catheter and method and system for securing a stent to a balloon catheter | |
WO2004105646A2 (en) | Devices and methods for treatment of stenotic regions | |
JP2006507084A (en) | Stent delivery and retention device | |
JP2003523268A (en) | Stent delivery balloon having stent fixing means | |
WO2004021929A1 (en) | Modular stent system and delivery means |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003812090 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2512172 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004564960 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003812090 Country of ref document: EP |